Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study - Concepedia

Concepedia

Publication | Closed Access

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

444

Citations

16

References

2007

Year

Anthony J. Swerdlow, Craig Higgins, Paul Smith, David Cunningham, Barry W. Hancock, Alan Horwich, Peter Hoskin, Andrew Lister, John Radford, A. Z. S. Rohatiner,

JNCI Journal of the National Cancer Institute

Abstract

The risk of death from myocardial infarction after treatment for Hodgkin disease remains high for at least 25 years. The increased risks are related to supradiaphragmatic radiotherapy but may also be related to anthracycline and vincristine treatment.

References

	Year	Citations

Page 1